OraSure Technologies, Inc. (OSUR)
$
2.88
+0.04 (1.39%)
Key metrics
Financial statements
Free cash flow per share
-0.0232
Market cap
188.5 Million
Price to sales ratio
2.0273
Debt to equity
0.0358
Current ratio
12.3429
Income quality
-0.0282
Average inventory
34.9 Million
ROE
-0.0771
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
OraSure Technologies, Inc., along with its subsidiaries, develops, manufactures, markets, and sells various oral fluid diagnostic products and specimen collection devices across the United States, Europe, and internationally. The operating income ratio is -0.15 indicating the company's operational profitability margin. Additionally, the gross profit ratio stands at 0.43 reflecting the efficiency of the company's production and sales operations. Notably, the gross profit amounts to $79,390,000.00 highlighting the company's profitability from its core operations. Furthermore, the company reported depreciation and amortization expenses of $10,872,000.00 which reflect the wear and tear on its assets. Alongside this, selling, general, and administrative expenses totaled $77,201,000.00 indicating the operational overhead costs the company incurs in its day-to-day functioning. OraSure operates in two segments: Diagnostics and Molecular Solutions, offering a suite of products such as the InteliSwab COVID-19 rapid tests, OraQuick Rapid HIV tests, and the Intercept drug testing systems, while also providing genomic and microbiome collection products. With a market capitalization of $215,424,288.00 the company is classified as a small-cap player in the Medical - Instruments & Supplies industry, contributing significantly to the overall market landscape. The stock is affordable at $2.84 making it suitable for budget-conscious investors. It belongs to the Healthcare sector, driving innovation and growth within its field. The stock has an average trading volume of 684,339.00 indicating moderate liquidity, ensuring that there is adequate trading activity for investors. OraSure Technologies continues to thrive by catering to a diverse customer base, including clinical laboratories, hospitals, and public health organizations, while also expanding its product offerings in the genomics and diagnostic spaces.
Is OraSure Technologies, Inc. (OSUR) a good investment?
Investing in OraSure Technologies, Inc. (OSUR) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C, with a Bullish outlook. Always conduct your own research before investing.
What is OraSure Technologies, Inc. (OSUR)'s stock forecast?
Analysts predict OraSure Technologies, Inc. stock to fluctuate between $2.36 (low) and $4.98 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is OraSure Technologies, Inc.'s market capitalization?
As of 2025-05-30, OraSure Technologies, Inc.'s market cap is $215,424,288, based on 74,800,100 outstanding shares.
How does OraSure Technologies, Inc. compare to competitors like Eli Lilly & Co.?
Compared to Eli Lilly & Co., OraSure Technologies, Inc. has a Lower Market-Cap, indicating a difference in performance.
Does OraSure Technologies, Inc. pay dividends?
OraSure Technologies, Inc. pays dividends. The current dividend yield is 30.84%, with a payout of $1.60 per share.
How can I buy OraSure Technologies, Inc. (OSUR) stock?
To buy OraSure Technologies, Inc. (OSUR) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for OSUR. Place an order (Market, Limit, etc.).
What is the best time to invest in OraSure Technologies, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Has OraSure Technologies, Inc. stock ever split?
OraSure Technologies, Inc.'s last stock split was 3:1 on 1987-04-08.
How did OraSure Technologies, Inc. perform in the last earnings report?
Revenue: $185,827,000 | EPS: -$0.26 | Growth: -135.62%.
Where can I find OraSure Technologies, Inc.'s investor relations reports?
Visit https://www.orasure.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for OraSure Technologies, Inc.?
You can explore historical data from here
What is the all-time high and low for OraSure Technologies, Inc. stock?
All-time high: $15.94 (2021-02-01) | All-time low: $2.36 (2025-05-15).
What are the key trends affecting OraSure Technologies, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
seekingalpha.com
OraSure Technologies, Inc. (NASDAQ:OSUR ) Q1 2025 Earnings Conference Call May 7, 2025 5:00 PM ET Company Participants Jason Plagman - VP of Investor Relations Carrie Eglinton Manner - President & Chief Executive Officer Ken McGrath - Chief Financial Officer Conference Call Participants Patrick Donnelly - Citi Vijay Kumar - Evercore ISI Andrew Cooper - Raymond James Operator Good day, and thank you for standing by. Welcome to the OraSure Technologies, Inc. 2025 First Quarter Earnings Conference Call.
seekingalpha.com
OraSure Technologies shares have dipped below $3 since my last writing, making shares even cheaper. Recent developments at the company include the acquisition of Sherlock Biosciences and the announcement of a $40 million share repurchase program. OSUR is enhancing business efficiency through cost cuts and aims to expand gross margins to 50% by year-end 2025, mitigating acquisition-related cash burn.
globenewswire.com
BETHLEHEM, Pa., March 24, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (the “Company”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that its Board of Directors has authorized the repurchase of up to $40 million of its common stock over the next twenty-four months, which will be funded from cash on hand.
seekingalpha.com
OraSure Technologies, Inc. (NASDAQ:OSUR ) Q4 2024 Results Conference Call February 25, 2025 5:00 PM ET Company Participants Jason Plagman - VP of Investor Relations Carrie Eglinton Manner - President & Chief Executive Officer Ken McGrath - Chief Financial Officer Conference Call Participants Jacob Johnson - Stephens Casey Woodring - JPMorgan Andrew Cooper - Raymond James Operator Welcome to the OraSure Technologies, Inc. 2024 Fourth Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
zacks.com
OraSure Technologies (OSUR) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to earnings of $0.22 per share a year ago.
globenewswire.com
BETHLEHEM, Pa., Feb. 14, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering fourth quarter 2024 financial results and certain business developments for 5 p.m. ET on February 25, 2025.
See all news
